What is Global Automated Immunoassay Analyzer Market?
The Global Automated Immunoassay Analyzer Market is a vast and dynamic sector that has seen significant growth in recent years. This market revolves around the production and distribution of automated immunoassay analyzers, which are medical devices used to conduct biochemical tests to detect the presence and concentration of substances in patient samples. These analyzers are crucial in diagnosing and monitoring various diseases, making them an essential part of the healthcare industry. The global market for these devices was valued at a substantial US$ 3170.8 million in 2023 and is projected to reach an impressive US$ 5019.2 million by 2030. This growth is driven by advancements in technology, increasing healthcare expenditure, and the rising prevalence of chronic diseases worldwide.
Benchtop Automated Immunoassay Analyzer, Floor-standing Automated Immunoassay Analyzer in the Global Automated Immunoassay Analyzer Market:
The Global Automated Immunoassay Analyzer Market is segmented into two main types of analyzers: Benchtop and Floor-standing. Benchtop analyzers are compact, portable, and ideal for small to medium-sized laboratories. They offer high throughput and are designed to handle a wide range of assays. On the other hand, Floor-standing analyzers are larger, more powerful devices designed for high-volume testing in large laboratories and hospitals. They offer greater capacity and faster processing times, making them suitable for handling a high number of samples simultaneously. Both types of analyzers play a crucial role in the global market, catering to different needs and requirements of various healthcare settings.
Chemiluminescence Analysis, Fluorescent Immunoassay, Radioimmunoassay, Enzyme Immunoassay, Others in the Global Automated Immunoassay Analyzer Market:
The Global Automated Immunoassay Analyzer Market finds its application in several areas, including Chemiluminescence Analysis, Fluorescent Immunoassay, Radioimmunoassay, Enzyme Immunoassay, among others. Chemiluminescence Analysis, which involves the emission of light during a chemical reaction, is the most widely used application, accounting for about 63% of the market in 2019. Fluorescent Immunoassay and Radioimmunoassay are also popular techniques, used for detecting and quantifying specific antigens or antibodies in a sample. Enzyme Immunoassay, on the other hand, uses enzymes as labels to detect the presence of target molecules. Each of these applications has its advantages and limitations, and their usage depends on the specific requirements of the test.
Global Automated Immunoassay Analyzer Market Outlook:
Looking at the market outlook, the Global Automated Immunoassay Analyzer Market was valued at a significant US$ 3170.8 million in 2023 and is expected to reach a staggering US$ 5019.2 million by 2030. This indicates a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period from 2024 to 2030. The largest share of the Automated Immunoassay Analyzer usage is in Chemiluminescence Analysis, with a proportion of about 63% in 2019. Geographically, North America holds the largest consumption market share, accounting for nearly 43.3% in 2019. This can be attributed to the advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players in the region.
Report Metric | Details |
Report Name | Automated Immunoassay Analyzer Market |
Accounted market size in 2023 | US$ 3170.8 million |
Forecasted market size in 2030 | US$ 5019.2 million |
CAGR | 6.7% |
Base Year | 2023 |
Forecasted years | 2024 - 2030 |
Segment by Type |
|
Segment by Application |
|
Consumption by Region |
|
By Company | Roche Diagnostics, Abbott, Danaher, Siemens Healthcare, BioMerieux, Ortho Clinical Diagnostics, DiaSorin, Tosoh, Euroimmun, Snibe, Inova Diagnostics, Maccura Biotechnology, Leadman Biochemistry |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |